venBio Select Advisor »

Structure Therapeutics shares owned by venBio Select Advisor

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by venBio Select Advisor from 13F filings

Historical chart of venBio Select Advisor investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by venBio Select Advisor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by venBio Select Advisor

Quarter filed Position value Share count Share price at filing
2023-12-31 $95M 2.3M 40.76
2023-09-30 $50M 1.0M 50.42

More positions owned by venBio Select Advisor

Apellis Pharmaceuticals Common (APLS)
United Therapeutics Corp Common (UTHR)
Ascendis Pharma Sponsored ADR (ASND)
Argenx Se Sponsored ADR (ARGX)
Madrigal Pharmaceuticals Common (MDGL)
Sarepta Therapeutics Common (SRPT)
Biomarin Pharmaceutical Common (BMRN)
Spdr Series Trust - S&p Biotech Etf (XBI)
Amicus Therapeutics Common (FOLD)
Cerevel Therapeutics Hldng Common (CERE)
Krystal Biotech Common (KRYS)
Mirati Therapeutics Common
Cymabay Therapeutics Common
Xenon Pharmaceuticals Common (XENE)
Alnylam Pharmaceuticals Common (ALNY)

View all positions for venBio Select Advisor

Top funds holding Structure Therapeutics

Wellington Management Company
venBio Select Advisor
Federated Investors
Avidity Partners Management
T. Rowe Price Associates
Henderson Group
Citadel Advisors
Casdin Capital
Logos Global Management
Sc China Holding
Deerfield Management Company
BVF
Caption Management
Franklin Resources
RA Capital Management

View all funds holding Structure Therapeutics